Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A new Bayesian method to forecast and fine tune individual hemodialysis dose.

Pfister M, Uehlinger DE, Hung AM, Schaedeli F, Sheiner LB.

Hemodial Int. 2004 Jul 1;8(3):244-56. doi: 10.1111/j.1492-7535.2004.01102.x.

PMID:
19379424
2.

The willingness of patients to accept an additional mortality risk in order to improve renal graft survival.

Girardi V, Schaedeli F, Marti HP, Frey FJ, Uehlinger DE.

Kidney Int. 2004 Jul;66(1):375-82.

3.

Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation.

Schaedeli F, Pitsiu M, Benowitz NL, Gourlay SG, Verotta D.

J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):49-66.

PMID:
12194535
4.

Non-linear dynamics models characterizing long-term virological data from AIDS clinical trials.

Verotta D, Schaedeli F.

Math Biosci. 2002 Apr;176(2):163-83.

PMID:
11916507
5.

Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis.

Pfister M, Schaedeli F, Frey FJ, Uehlinger DE.

Br J Clin Pharmacol. 1999 Jun;47(6):645-51.

6.

Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.

Schaedeli F, Uehlinger DE.

Clin Pharmacol Ther. 1998 Jan;63(1):26-38.

PMID:
9465839
7.

Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.

Uehlinger DE, Schaedeli F, Kinzig M, Sörgel F, Frey FJ.

Antimicrob Agents Chemother. 1996 Aug;40(8):1903-9.

Supplemental Content

Loading ...
Support Center